CopyMark Law Group
4.9/5
Drawing for PHARMACY ADVISOR LEADERS

USPTO serial 87148054

PHARMACY ADVISOR LEADERS

Reviewed by CopyMark Law Group

Reg. 5180662Status 702Renewal
Filing date
Status date
Registration date
Apr 11, 2017
Examiner
MORENO, PAUL A
Law office
TMEG LAW OFFICE 103

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with PHARMACY ADVISOR LEADERS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $1,950

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
035Business administration services, namely, developing and maintaining formulary, contracting with pharmacies and negotiating discounts and rebates with drug manufacturerACTIVEJan 21, 2016
036Insurance services, namely, underwriting, issuance, management, and administration of prescription drug programs; claims administration services in the field of prescription drug insurance; processing and paying prescription drug insurance claims; and provide secondary prescription drug plan insurance for senior citizens to supplement their Medicare prescription drug plansACTIVEJan 21, 2016
041Educational services, namely, providing conferences, conventions, colloquiums, training, seminars, and educational publications in the fields of healthcare, insurance, pharmaceuticals, and prescription drug programsACTIVEJan 21, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 11, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Apr 30, 2025ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 27, 2024WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Nov 27, 2024WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Feb 21, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 4, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 4, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 4, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 14, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 14, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 14, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 3, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Jan 25, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 11, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 30, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 30, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 30, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 30, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 30, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 11, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 24, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 24, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 4, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 15, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 15, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Dec 15, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 15, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 15, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 8, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2016DOCKASSIGNED TO EXAMINER—
Aug 29, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 26, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance